<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CMYNFHSP</identifier><date>2023</date><creator>Knez, Lea</creator><creator>Laptoš, Tomislav</creator><creator>Petre, Maja</creator><creator>Štuhec, Matej</creator><relation>documents/doc/C/URN_NBN_SI_doc-CMYNFHSP_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CMYNFHSP_001.txt</relation><format format_type="issue">5</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 379-381</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">190644483</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CMYNFHSP</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">klinična farmacija</subject><subject language_type_id="slv">srečanja</subject><title>Kongres Evropskega združenja za klinično farmacijo 2023 3 (European Society of Clinical Pharmacy Aberdeen Symposium 2023) – utrinki slovenskih udeležencev</title></Record>